Table 2. Characteristics of patients with gene mutations.
Patient | Gene | Amino-acid substitution | Gender | Age | Histotype | Asbestos exposure | DSS |
---|---|---|---|---|---|---|---|
1 | KRAS | G12V | Male | 81 | Sarcomatoid | Yes | 4 |
2 | G12V | Male | 55 | Epithelioid | Yes | 14 | |
3 | G13D | Male | 82 | Epithelioid | Yes | 4 | |
4 | G13S | Male | 60 | Epithelioid | Yes | 5 | |
5 |
|
G13D |
Male |
77 |
Biphasic |
Yes |
19 |
6 | BRAF | V600E | Female | 51 | Epithelioid | None | 9 |
7 | V600E | Male | 57 | Biphasic | None | 19 | |
8 |
|
V600E |
Male |
73 |
Epithelioid |
None |
33 |
9 | PIK3CA | M1040I | Male | 68 | Biphasic | None | 7 |
Abbreviation: DSS=disease-specific survival.